We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Buys

Rank Stock Value
1
TCPC icon
BlackRock TCP Capital
TCPC
+$1.06M
2
HST icon
Host Hotels & Resorts
HST
+$965K
3
PLTR icon
Palantir
PLTR
+$932K
4
PSA icon
Public Storage
PSA
+$920K
5
DFS
Discover Financial Services
DFS
+$865K

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
376
Biomea Fusion
BMEA
$88.2M
$92.2K 0.05%
6,166
-423
-6% -$6.96K
ZNTL icon
377
Zentalis Pharmaceuticals
ZNTL
$332M
$91.3K 0.05%
5,790
-399
-6% -$5.49K
REPL icon
378
Replimune Group
REPL
$455M
$91.2K 0.05%
11,165
-766
-6% -$6.28K
RXRX icon
379
Recursion Pharmaceuticals
RXRX
$1.58B
$90.7K 0.05%
9,093
-622
-6% -$6.93K
XENE icon
380
Xenon Pharmaceuticals
XENE
$6.1B
$90.5K 0.05%
2,103
-142
-6% -$6.53K
XNCR icon
381
Xencor
XNCR
$1.45B
$90.4K 0.05%
4,087
-276
-6% -$5.96K
TERN
382
DELISTED
Terns Pharmaceuticals
TERN
$87.7K 0.05%
13,372
-915
-6% -$5.97K
RGNX icon
383
Regenxbio
RGNX
$616M
$87.6K 0.05%
4,159
-288
-6% -$5.13K
VIR icon
384
Vir Biotechnology
VIR
$1.46B
$87.4K 0.05%
8,630
-591
-6% -$6.02K
ARWR icon
385
Arrowhead Research
ARWR
$12.1B
$86.7K 0.05%
3,031
-212
-7% -$6.78K
EXAI
386
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$84K 0.04%
14,684
-1,008
-6% -$6.26K
SRRK icon
387
Scholar Rock
SRRK
$5.88B
$83K 0.04%
4,671
-317
-6% -$4.99K
RCKT icon
388
Rocket Pharmaceuticals
RCKT
$343M
$82.5K 0.04%
3,063
-211
-6% -$5.99K
NUVL
389
DELISTED
Nuvalent
NUVL
$82.3K 0.04%
1,096
-76
-6% -$6.05K
NMRA icon
390
Neumora Therapeutics
NMRA
$306M
$81.4K 0.04%
5,918
-410
-6% -$6.63K
SLRN
391
DELISTED
ACELYRIN
SLRN
$80.3K 0.04%
11,901
-816
-6% -$6.2K
VERV
392
DELISTED
Verve Therapeutics
VERV
$80.3K 0.04%
6,046
-419
-6% -$5.56K
OLMA icon
393
Olema Pharmaceuticals
OLMA
$977M
$79.6K 0.04%
7,030
-485
-6% -$6.26K
DVAX
394
DELISTED
Dynavax Technologies
DVAX
$79.2K 0.04%
6,382
-441
-6% -$5.75K
VRDN icon
395
Viridian Therapeutics
VRDN
$2.2B
$78.4K 0.04%
4,479
-308
-6% -$5.97K
PLRX icon
396
Pliant Therapeutics
PLRX
$65M
$77K 0.04%
5,167
-354
-6% -$5.84K
DNLI icon
397
Denali Therapeutics
DNLI
$3.79B
$76.6K 0.04%
3,735
-259
-6% -$4.87K
MLTX icon
398
MoonLake Immunotherapeutics
MLTX
$1.56B
$75.5K 0.04%
1,504
-101
-6% -$5.48K
BLTE
399
Belite Bio
BLTE
$6.11B
$75.2K 0.04%
1,959
-137
-7% -$6.13K
NTLA icon
400
Intellia Therapeutics
NTLA
$1.51B
$74.8K 0.04%
2,719
-187
-6% -$5.19K
14 15
16
17 18

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.